BIOMAT Database Logo BIOMAT Database Logo

Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. 1977

E C Keystone, and H U Schorlemmer, and C Pope, and A C Allison

Zymosan particles, which are able to activate complement by the alternative pathway and to induce enzyme secretion from macrophages, were injected into knee joints of mice. After various time intervals, synovia were assessed histologically for various markers of inflammation. Within 7 days after intraarticular injection of zymosan, a chronic inflammatory arthritis with mononuclear cell infiltration, synovial hypertrophy and pannus formation was observed. Latex particles, which do not activate complement or macrophages, produced only mild, transient inflammatory reactions.

UI MeSH Term Description Entries
D006984 Hypertrophy General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA). Hypertrophies
D007270 Injections, Intra-Articular Methods of delivering drugs into a joint space. Intra Articular Injection,Intraarticular Injection,Injections, Intraarticular,Intra-Articular Injections,Intraarticular Injections,Articular Injection, Intra,Articular Injections, Intra,Injection, Intra Articular,Injection, Intra-Articular,Injection, Intraarticular,Injections, Intra Articular,Intra Articular Injections,Intra-Articular Injection
D007840 Latex A milky, product excreted from the latex canals of a variety of plant species that contain cauotchouc. Latex is composed of 25-35% caoutchouc, 60-75% water, 2% protein, 2% resin, 1.5% sugar & 1% ash. RUBBER is made by the removal of water from latex.(From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed). Hevein proteins are responsible for LATEX HYPERSENSITIVITY. Latexes are used as inert vehicles to carry antibodies or antigens in LATEX FIXATION TESTS. Latices,Latice
D008863 Microspheres Small uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers. Latex Beads,Latex Particles,Latex Spheres,Microbeads,Bead, Latex,Beads, Latex,Latex Bead,Latex Particle,Latex Sphere,Microbead,Microsphere,Particle, Latex,Particles, Latex,Sphere, Latex,Spheres, Latex
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D005260 Female Females
D006644 Histiocytes Macrophages found in the TISSUES, as opposed to those found in the blood (MONOCYTES) or serous cavities (SEROUS MEMBRANE). Histiocyte
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

E C Keystone, and H U Schorlemmer, and C Pope, and A C Allison
Inhibition of zymosan-induced alternative complement pathway activation by concanavalin A.
December 1982, Infection and immunity,
E C Keystone, and H U Schorlemmer, and C Pope, and A C Allison
The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
January 1981, Journal of immunology (Baltimore, Md. : 1950),
E C Keystone, and H U Schorlemmer, and C Pope, and A C Allison
Alternative pathway complement activation in rheumatoid arthritis.
January 1980, The Journal of rheumatology,
E C Keystone, and H U Schorlemmer, and C Pope, and A C Allison
Cutting Edge: A New Player in the Alternative Complement Pathway, MASP-1 Is Essential for LPS-Induced, but Not for Zymosan-Induced, Alternative Pathway Activation.
April 2018, Journal of immunology (Baltimore, Md. : 1950),
E C Keystone, and H U Schorlemmer, and C Pope, and A C Allison
The alternative pathway of complement activation.
January 1976, Advances in immunology,
E C Keystone, and H U Schorlemmer, and C Pope, and A C Allison
Activation of the alternative complement pathway.
November 1979, CRC Critical reviews in immunology,
E C Keystone, and H U Schorlemmer, and C Pope, and A C Allison
Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.
August 2006, Journal of immunology (Baltimore, Md. : 1950),
E C Keystone, and H U Schorlemmer, and C Pope, and A C Allison
Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway.
September 2007, Journal of immunology (Baltimore, Md. : 1950),
E C Keystone, and H U Schorlemmer, and C Pope, and A C Allison
Activation of human complement by liposomes: a model for membrane activation of the alternative pathway.
April 1979, Journal of immunology (Baltimore, Md. : 1950),
E C Keystone, and H U Schorlemmer, and C Pope, and A C Allison
Activation of complement via the alternative pathway.
January 1983, Federation proceedings,
Copied contents to your clipboard!